Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Wuhan Keqian Biology Co Ltd

688526:SHH

Wuhan Keqian Biology Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)15.19
  • Today's Change0.34 / 2.29%
  • Shares traded3.86m
  • 1 Year change-21.86%
  • Beta1.6869
Data delayed at least 15 minutes, as of Nov 05 2024 07:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Wuhan Keqian Biology Co Ltd is a China-based company mainly engaged in the research and development, production, sales of veterinary biological products and the provision of animal epidemic prevention technical services. The Company's main products are vaccines for swine and poultry. The Company mainly conducts its businesses within the China market.

  • Revenue in CNY (TTM)902.14m
  • Net income in CNY299.11m
  • Incorporated2001
  • Employees923.00
  • Location
    Wuhan Keqian Biology Co LtdNo. 419, Gaoxin 2nd Road, DonghuNew Technology Development ZoneWUHAN 430073ChinaCHN
  • Phone+86 2 781322905
  • Fax+86 2 781322905
  • Websitehttp://www.kqbio.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Jianmin Pharmaceutical Group Co Ltd3.98bn427.95m6.70bn2.50k15.612.80--1.682.802.8025.9815.610.97936.994.161,592,652.0010.6210.8718.4919.1142.3443.0410.849.321.38--0.149237.1515.7214.2827.7845.058.7743.10
Sichuan Huiyu Pharmaceutical Co Ltd1.12bn278.20m6.82bn1.36k24.521.76--6.090.65670.65672.649.160.23351.1821.25820,954.905.6610.417.0812.7683.4089.8924.2321.422.57--0.148820.54-37.9276.37-43.86--66.72--
Shanghai Fudan-Zhangjiang Bio-Pharm. Co691.62m105.20m6.90bn948.0085.743.77--9.970.09980.09980.65092.270.24821.531.50729,558.103.767.034.439.0590.2492.1715.1517.266.06--0.004826.31-17.502.78-21.28-0.632620.49--
Wuhan Keqian Biology Co Ltd902.14m299.11m6.92bn923.0023.191.79--7.670.64040.64041.938.280.19682.442.47977,402.106.5113.297.6215.4963.8776.4933.0845.714.71--0.020924.766.277.67-3.320.355627.17--
Lushang Freda Pharmaceutical Co Ltd3.99bn236.52m6.93bn3.65k29.311.70--1.740.23270.23273.924.020.46940.79417.741,091,879.003.230.69925.935.1248.7320.236.873.452.96--0.089640.33-64.65-12.29567.4413.3644.4014.87
Zhejiang Ausun Pharmaceutical Co Ltd835.23m257.55m7.00bn1.17k27.103.05--8.380.31110.31111.012.760.27881.092.84711,439.108.609.3811.3512.8454.3453.0930.8427.142.00--0.15623.536.8327.357.8742.0724.3250.48
JiangSu WuZhong Pharmactcl Devlpm Co Ltd2.38bn-37.82m7.00bn1.05k--3.90--2.94-0.055-0.0553.342.520.568417.732.042,270,402.00-0.8772-2.92-1.79-5.3028.0728.14-1.54-5.771.460.51270.4841--10.555.655.58---19.08--
China Animal Husbandry Industry Co., Ltd5.43bn87.90m7.02bn4.33k79.821.28--1.290.08610.08615.315.370.61274.563.761,254,216.000.70856.231.009.0116.4224.291.168.691.54--0.190931.20-8.244.04-26.73-0.612724.20-3.77
Data as of Nov 05 2024. Currency figures normalised to Wuhan Keqian Biology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

2.67%Per cent of shares held by top holders
HolderShares% Held
Penghua Fund Management Co., Ltd.as of 30 Jun 20242.11m0.45%
Bosera Asset Management Co., Ltd.as of 30 Jun 20241.78m0.38%
First Seafront Fund Management Co., Ltd.as of 30 Jun 20241.68m0.36%
China Merchants Fund Management Co., Ltd.as of 30 Jun 20241.68m0.36%
China Asset Management Co., Ltd.as of 30 Jun 20241.34m0.29%
China Southern Asset Management Co., Ltd.as of 30 Jun 20241.19m0.26%
Chang Xin Asset Management Co., Ltd.as of 30 Jun 2024792.36k0.17%
The Vanguard Group, Inc.as of 02 Oct 2024736.47k0.16%
Guotai Asset Management Co., Ltd.as of 30 Jun 2024580.95k0.13%
Golden Eagle Asset Management Co., Ltd.as of 30 Jun 2024566.74k0.12%
More ▼
Data from 30 Jun 2024 - 29 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.